市場調査レポート
商品コード
1181674

睡眠時無呼吸向け機器の世界市場 - 見通しと予測(2022年~2027年)

Sleep Apnea Devices Market - Global Outlook & Forecast 2022-2027

出版日: | 発行: Arizton Advisory & Intelligence | ページ情報: 英文 341 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.96円
睡眠時無呼吸向け機器の世界市場 - 見通しと予測(2022年~2027年)
出版日: 2023年01月10日
発行: Arizton Advisory & Intelligence
ページ情報: 英文 341 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の睡眠時無呼吸向け機器の市場規模は、2022年~2027年にCAGRで7.07%の成長が予測されています。市場の成長は、睡眠時無呼吸の高い有病率、潜在的なリスク要因の増加、睡眠時無呼吸向け機器の技術の進歩、高齢化の進行などの要因に起因しています。

当レポートでは、世界の睡眠時無呼吸向け機器市場について調査分析し、市場規模と予測、促進要因、競合情勢などを提供しています。

目次

第1章 調査手法

第2章 調査目的

第3章 調査プロセス

第4章 範囲

第5章 レポートの前提条件と注意事項

第6章 市場の概要

第7章 主要考察

  • 市場の概要
    • 市場力学
    • 市場セグメンテーション
    • ベンダー分析
    • 最近の発展

第8章 イントロダクション

  • 概要
    • 危険因子
    • 睡眠時無呼吸の診断
    • 睡眠時無呼吸の治療

第9章 市場機会と動向

第10章 市場の成長促進要因

第11章 市場抑制要因

第12章 市場情勢

  • 市場の概要
  • 市場規模と予測
    • 考察:地域別
    • 考察:製品別
    • 考察:年齢層別
    • 考察:性別
    • 考察:エンドユーザー別
  • ファイブフォース分析

第13章 製品

  • 市場のスナップショットと成長エンジン
  • 市場の概要
  • 治療機器
  • フェイシャルインターフェース
  • 診断機器

第14章 年齢層

  • 市場のスナップショットと成長エンジン
  • 市場の概要
  • 41歳~60歳
  • 61歳以上
  • 40歳未満

第15章 性別

  • 市場のスナップショットと成長エンジン
  • 市場の概要
  • 男性
  • 女性

第16章 エンドユーザー

  • 市場のスナップショットと成長エンジン
  • 市場の概要
  • 睡眠クリニック/研究所
  • 在宅医療環境
  • 病院
  • その他

第17章 地域

  • 市場のスナップショットと成長エンジン
  • 地理的概要

第18章 北米

  • 市場の概要
  • 市場規模と予測
    • 北米:製品北米
    • 北米:年齢層別
    • 北米:性別
    • 北米:エンドユーザー別
  • 主要国
    • 米国:市場規模と予測
    • カナダ:市場規模と予測

第19章 欧州

  • 市場の概要
  • 市場規模と予測
    • 欧州:製品別
    • 欧州:年齢層別
    • 欧州:性別
    • 欧州:エンドユーザー別
  • 主要国
    • ドイツ:市場規模と予測
    • フランス:市場規模と予測
    • 英国:市場規模と予測
    • イタリア:市場規模と予測
    • スペイン:市場規模と予測

第20章 アジア太平洋

  • 市場の概要
  • 市場規模と予測
    • アジア太平洋:製品別
    • アジア太平洋:年齢層別
    • アジア太平洋:性別
    • アジア太平洋:エンドユーザー別
  • 主要国
    • 中国:市場規模と予測
    • 日本:市場規模と予測
    • インド:市場規模と予測
    • 韓国:市場規模と予測
    • オーストラリア:市場規模と予測

第21章 ラテンアメリカ

  • 市場の概要
  • 市場規模と予測
    • ラテンアメリカ:製品別
    • ラテンアメリカ:年齢層別
    • ラテンアメリカ:性別
    • ラテンアメリカ:エンドユーザー別
  • 主要国
    • ブラジル:市場規模と予測
    • メキシコ:市場規模と予測
    • アルゼンチン:市場規模と予測

第22章 中東・アフリカ

  • 市場の概要
  • 市場規模と予測
    • 中東・アフリカ:製品別
    • 中東・アフリカ:年齢層別
    • 中東・アフリカ:性別
    • 中東・アフリカ:エンドユーザー別
  • 主要国
    • トルコ:市場規模と予測
    • サウジアラビア:市場規模と予測
    • 南アフリカ:市場規模と予測

第23章 競合情勢

  • 競合の概要
  • 市場シェア分析

第24章 主要企業プロファイル

  • NIHON KOHDEN CORPORATION
  • BMC MEDICAL
  • DRIVE DEVILBISS HEALTHCARE
  • SOMNOMED
  • GLIDEWELL
  • RESMED
  • KONINKLIJKE PHILIPS N.V
  • FISHER & PAYKEL HEALTHCARE
  • COMPUMEDICS LIMITED
  • INSPIRE MEDICAL SYSTEMS
  • NATUS MEDICAL
  • ITAMAR MEDICAL

第25章 その他の著名なベンダー

  • APEX MEDICAL
  • CADWELL INDUSTRIES
  • SOMNOMEDICS
  • CLEVELAND MEDICAL DEVICES
  • PROSOMNUS SLEEP TECHNOLOGIES
  • MEDITAS
  • WHITE DENTAL HEALTHCARE
  • OVENTUS
  • TOMED
  • SIGNIFIER MEDICAL TECHNOLOGIES
  • APNEAMED
  • NYXOAH
  • VIVOS THERAPEUTICS
  • SOMNOWELL
  • REMSLEEP HOLDINGS
  • SIESTA MEDICAL
  • HORIZON PRIME
  • NOX MEDICAL
  • ONERA HEALTH
  • LIVANOVA
  • ZOLL MEDICAL
  • BRAEBON MEDICAL
  • INVACARE
  • BREAS MEDICAL

第26章 レポートサマリー

  • 重要事項
  • 戦略的推奨事項

第27章 定量的要約

第28章 付録

図表

LIST OF EXHIBITS

  • EXHIBIT 1 SEGMENTATION OF GLOBAL SLEEP APNEA DEVICES MARKET
  • EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
  • EXHIBIT 3 GLOBAL SLEEP APNEA DEVICES MARKET 2021 & 2027 ($ MILLION)
  • EXHIBIT 4 GLOBAL SLEEP APNEA DEVICES MARKET SEGMENTATION
  • EXHIBIT 5 SYMPTOMS OF OSA
  • EXHIBIT 6 RISK FACTORS FOR SLEEP APNEA
  • EXHIBIT 7 IMPACT OF IMPLEMENTATION OF AI IN SLEEP APNEA TREATMENTS
  • EXHIBIT 8 IMPACT OF GROWING DEMAND AND ADVANCES IN HSATS
  • EXHIBIT 9 THE ADVANTAGES OF TAKING A HOME SLEEP APNEA TEST
  • EXHIBIT 10 IMPACT OF GROWING ADOPTION OF TELEMEDICINE, MHEALTH IN SLEEP APNEA TREATMENT
  • EXHIBIT 11 ADVANTAGES OF TELEMEDICINE IN THE MANAGEMENT OF SLEEP APNEA
  • EXHIBIT 12 TELEHEALTH CONSULTATION SCHEDULED AND COMPLETED BY EMERGING NON-CPAP VENDOR
  • EXHIBIT 13 IMPACT OF GROWING POPULARITY OF NON-CPAP DEVICES FOR SLEEP APNEA TREATMENT
  • EXHIBIT 14 PATIENTS STRUGGLE WITH CONVENTIONAL TREATMENT WAYS
  • EXHIBIT 15 IMPACT OF IMPROVEMENTS IN SLEEP APNEA DIAGNOSIS
  • EXHIBIT 16 ROLE OF SENSORS & REMOTE MONITORING IN SLEEP APNEA DIAGNOSIS
  • EXHIBIT 17 IMPACT OF TECHNOLOGICAL ADVANCES IN CPAP THERAPY
  • EXHIBIT 18 IMPACT OF INCREASING TARGET PATIENT POPULATION
  • EXHIBIT 19 TYPE 2 DIABETES STATISTICS (MILLION)
  • EXHIBIT 20 SIGNIFICANT COMORBIDITIES OF CARDIOVASCULAR DISEASES FOR SLEEP APNEA
  • EXHIBIT 21 IMPACT OF HIGH GROWTH POTENTIAL FOR UPPER AIRWAY STIMULATION THERAPY (IMPLANT) SYSTEM
  • EXHIBIT 22 IMPACT OF PRESENCE ON NUMEROUS UNDIAGNOSED PATIENTS
  • EXHIBIT 23 IMPACT OF HIGH COST OF SLEEP APNEA DEVICES
  • EXHIBIT 24 IMPACT OF AVAILABILITY OF SURGICAL OPTION TO TREAT SLEEP APNEA
  • EXHIBIT 25 IMPACT OF LACK OF PATIENT ADHERENCE TO CPAP DEVICE
  • EXHIBIT 26 GLOBAL SLEEP APNEA DEVICES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 27 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY: MARKET SHARE 2021 & 2027
  • EXHIBIT 28 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY: MARKET SHARE 2021 & 2027
  • EXHIBIT 29 GLOBAL SLEEP APNEA DEVICES MARKET BY AGE GROUP: MARKET SHARE 2021 & 2027
  • EXHIBIT 30 GLOBAL SLEEP APNEA DEVICES MARKET BY GENDER: MARKET SHARE 2021 & 2027
  • EXHIBIT 31 GLOBAL SLEEP APNEA DEVICES MARKET BY END-USER: MARKET SHARE 2021 & 2027
  • EXHIBIT 32 FIVE FORCES ANALYSIS 2021
  • EXHIBIT 33 INCREMENTAL GROWTH BY PRODUCT SEGMENT 2021 & 2027
  • EXHIBIT 34 GLOBAL SLEEP APNEA DEVICES MARKET BY PRODUCT
  • EXHIBIT 35 GLOBAL SLEEP APNEA DEVICES MARKET BY PRODUCT: INCREMENTAL GROWTH
  • EXHIBIT 36 GLOBAL SLEEP APNEA DEVICE TYPE
  • EXHIBIT 37 GLOBAL SLEEP APNEA DEVICES MARKET BY PRODUCT: ABSOLUTE GROWTH
  • EXHIBIT 38 GLOBAL THERAPEUTIC SLEEP APNEA DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 39 SILENT FEATURES OF APAP DEVICE
  • EXHIBIT 40 TYPES OF MADS
  • EXHIBIT 41 GLOBAL THERAPEUTIC SLEEP APNEA DEVICES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 42 CPAP MASK DESIGN & STRUCTURE
  • EXHIBIT 43 GLOBAL SLEEP APNEA DEVICES MARKET BY FACIAL INTERFACES: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 44 GLOBAL SLEEP APNEA DEVICES MARKET BY FACIAL INTERFACES 2021-2027 ($ MILLION)
  • EXHIBIT 45 GLOBAL DIAGNOSTICS SLEEP APNEA DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 46 GLOBAL DIAGNOSTICS SLEEP APNEA DEVICES MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 47 INCREMENTAL GROWTH BY AGE GROUP 2021 & 2027
  • EXHIBIT 48 GLOBAL SLEEP APNEA DEVICES MARKET BY AGE GROUP
  • EXHIBIT 49 GLOBAL SLEEP APNEA DEVICES MARKET BY AGE GROUP: INCREMENTAL GROWTH
  • EXHIBIT 50 GLOBAL SLEEP APNEA DEVICES MARKET BY AGE GROUP: ABSOLUTE GROWTH
  • EXHIBIT 51 GLOBAL SLEEP APNEA DEVICES MARKET BY BETWEEN 41 & 60 YEARS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 52 GLOBAL SLEEP APNEA DEVICES MARKET BY BETWEEN 41 & 60 YEARS 2021-2027 ($ MILLION)
  • EXHIBIT 53 GLOBAL SLEEP APNEA DEVICES MARKET BY 61 YEARS & ABOVE: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 54 GLOBAL SLEEP APNEA DEVICES MARKET BY 61 YEARS & ABOVE 2021-2027 ($ MILLION)
  • EXHIBIT 55 COMMON CAUSE OF OSA IN YOUNG ADULTS 18-40 YEARS OLD
  • EXHIBIT 56 GLOBAL SLEEP APNEA DEVICES MARKET BY BELOW 40 YEARS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 57 GLOBAL SLEEP APNEA DEVICES MARKET BY BELOW 40 YEARS 2021-2027 ($ MILLION)
  • EXHIBIT 58 INCREMENTAL GROWTH BY GENDER 2021 & 2027
  • EXHIBIT 59 GLOBAL SLEEP APNEA DEVICES MARKET BY GENDER
  • EXHIBIT 60 GLOBAL SLEEP APNEA DEVICES MARKET BY GENDER: INCREMENTAL GROWTH
  • EXHIBIT 61 GLOBAL SLEEP APNEA DEVICES MARKET BY GENDER: ABSOLUTE GROWTH
  • EXHIBIT 62 GLOBAL SLEEP APNEA DEVICES MARKET BY MALES: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 63 GLOBAL SLEEP APNEA DEVICES MARKET BY MALES 2021-2027 ($ MILLION)
  • EXHIBIT 64 GLOBAL SLEEP APNEA DEVICES MARKET BY FEMALES: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 65 GLOBAL SLEEP APNEA DEVICES MARKET BY FEMALES 2021-2027 ($ MILLION)
  • EXHIBIT 66 INCREMENTAL GROWTH BY END-USER 2021 & 2027
  • EXHIBIT 67 GLOBAL SLEEP APNEA DEVICES MARKET BY END-USER
  • EXHIBIT 68 GLOBAL SLEEP APNEA DEVICES MARKET BY END-USER: INCREMENTAL GROWTH
  • EXHIBIT 69 GLOBAL SLEEP APNEA DEVICES MARKET BY END-USER: ABSOLUTE GROWTH
  • EXHIBIT 70 GLOBAL SLEEP APNEA DEVICES MARKET BY SLEEP CLINICS/LABS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 71 GLOBAL SLEEP APNEA DEVICES MARKET BY SLEEP CLINICS/LABS 2021-2027 ($ MILLION)
  • EXHIBIT 72 GLOBAL SLEEP APNEA DEVICES MARKET BY HOME HEALTHCARE SETTINGS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 73 GLOBAL SLEEP APNEA DEVICES MARKET BY HOME HEALTHCARE SETTINGS 2021-2027 ($ MILLION)
  • EXHIBIT 74 GLOBAL SLEEP APNEA DEVICES MARKET BY HOME HEALTHCARE SETTINGS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 75 GLOBAL SLEEP APNEA DEVICES MARKET BY HOSPITALS 2021-2027 ($ MILLION)
  • EXHIBIT 76 GLOBAL SLEEP APNEA DEVICES MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 77 GLOBAL SLEEP APNEA DEVICES MARKET BY OTHER END-USERS 2021-2027 ($ MILLION)
  • EXHIBIT 78 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 79 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY
  • EXHIBIT 80 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY: KEY COUNTRIES 2021
  • EXHIBIT 81 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
  • EXHIBIT 82 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
  • EXHIBIT 83 SLEEP DEPRIVATION STATISTICS OF THE U.S.
  • EXHIBIT 84 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA: KEY COUNTRIES
  • EXHIBIT 85 GLOBAL SLEEP APNEA DEVICES MARKET BY NORTH AMERICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 86 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA 2021-2027 ($ MILLION)
  • EXHIBIT 87 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
  • EXHIBIT 88 PREVALENCE & TREATMENT RATE IN US
  • EXHIBIT 89 US WORK STRESS STATISTICS
  • EXHIBIT 90 SLEEP APNEA DEVICES MARKET IN US 2021-2027 ($ MILLION)
  • EXHIBIT 91 CANADIAN HEALTH MEASURES SURVEY (CHMS) 2016-2017
  • EXHIBIT 92 PREVALENCE OF SLEEP APNEA AMONG ADULTS AGED 18-79 YEARS
  • EXHIBIT 93 SLEEP APNEA DEVICES MARKET IN CANADA 2021-2027 ($ MILLION)
  • EXHIBIT 94 SLEEP APNEA DEVICES MARKET IN EUROPE: KEY COUNTRIES
  • EXHIBIT 95 PREVALENCE OF OSA IN EUROPEAN COUNTRIES IN 2018
  • EXHIBIT 96 GLOBAL SLEEP APNEA DEVICES MARKET BY EUROPE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 97 SLEEP APNEA DEVICES MARKET IN EUROPE 2021-2027 ($ MILLION)
  • EXHIBIT 98 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
  • EXHIBIT 99 SLEEP APNEA DEVICES MARKET IN GERMANY 2021-2027 ($ MILLION)
  • EXHIBIT 100 PREVALENCE OF OBESITY AMONG YOUNG PEOPLE BETWEEN 8 AND 17 YEARS
  • EXHIBIT 101 PREVALENCE OF TREATMENT FOR OSA WITH CPAP
  • EXHIBIT 102 SLEEP APNEA DEVICES MARKET IN FRANCE 2021-2027 ($ MILLION)
  • EXHIBIT 103 OSA AND ITS TREATMENT STATISTICS OF UK
  • EXHIBIT 104 SLEEP APNEA DEVICES MARKET IN UK 2021-2027 ($ MILLION)
  • EXHIBIT 105 SLEEP APNEA DEVICES MARKET IN ITALY 2021-2027 ($ MILLION)
  • EXHIBIT 106 SLEEP APNEA DEVICES MARKET IN SPAIN 2021-2027 ($ MILLION)
  • EXHIBIT 107 SLEEP APNEA DEVICES MARKET IN APAC: KEY COUNTRIES
  • EXHIBIT 108 SLEEP APNEA DEVICES MARKET IN APAC: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 109 LIST OF THE LEADING SLEEP APNEA DEVICE VENDOR IN APAC
  • EXHIBIT 110 SLEEP APNEA DEVICE MARKET IN APAC 2021-2027 ($ MILLION)
  • EXHIBIT 111 INCREMENTAL GROWTH IN APAC 2021 & 2027
  • EXHIBIT 112 SLEEP APNEA DEVICE MARKET IN CHINA 2021-2027 ($ MILLION)
  • EXHIBIT 113 SLEEP APNEA DEVICE MARKET IN JAPAN 2021-2027 ($ MILLION)
  • EXHIBIT 114 SLEEP APNEA DEVICES MARKET IN INDIA 2021-2027 ($ MILLION)
  • EXHIBIT 115 SLEEP APNEA DEVICE MARKET IN SOUTH KOREA 2021-2027 ($ MILLION)
  • EXHIBIT 116 SLEEP APNEA STATISTICS IN AUSTRALIA
  • EXHIBIT 117 SLEEP APNEA DEVICE MARKET IN AUSTRALIA 2021-2027 ($ MILLION)
  • EXHIBIT 118 SLEEP APNEA DEVICES MARKET IN LATIN AMERICA: KEY COUNTRIES
  • EXHIBIT 119 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA 2021-2027 ($ MILLION)
  • EXHIBIT 120 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
  • EXHIBIT 121 OSA STATISTICS IN BRAZIL 2016
  • EXHIBIT 122 OVERWEIGHT & OBESITY STATISTICS BY NATIONAL HEALTH SURVEY 2019
  • EXHIBIT 123 SLEEP APNEA DEVICE MARKET IN BRAZIL 2021-2027 ($ MILLION)
  • EXHIBIT 124 SLEEP APNEA DEVICES MARKET IN MEXICO 2021-2027 ($ MILLION)
  • EXHIBIT 125 SLEEP APNEA DEVICE MARKET IN ARGENTINA 2021-2027 ($ MILLION)
  • EXHIBIT 126 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA: KEY COUNTRIES
  • EXHIBIT 127 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH
  • EXHIBIT 128 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)
  • EXHIBIT 129 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
  • EXHIBIT 130 SLEEP APNEA DEVICE MARKET IN TURKEY 2021-2027 ($ MILLION)
  • EXHIBIT 131 SLEEP APNEA DEVICE MARKET IN SAUDI ARABIA 2021-2027 ($ MILLION)
  • EXHIBIT 132 SLEEP APNEA DEVICE MARKET IN SOUTH AFRICA 2021-2027 ($ MILLION)
  • EXHIBIT 133 GLOBAL SLEEP APNEA DEVICES MARKET: KEY VENDORS CAPABILITIES & EXPERTISE ASSESSMENT
  • EXHIBIT 134 GLOBAL SLEEP APNEA DEVICES MARKET: KEY VENDORS CAPABILITIES & EXPERTISE ASSESSMENT
  • EXHIBIT 135 GLOBAL SLEEP APNEA DEVICES MARKET: KEY VENDORS MARKET DOMINANCE ANALYSIS
  • EXHIBIT 136 GLOBAL SLEEP APNEA DEVICES MARKET: KEY VENDORS MARKET DOMINANCE ANALYSIS
  • EXHIBIT 137 NIHON KOHDEN CORPORATION: TOTAL REVENUE 2019-2021 ($ MILLION)
  • EXHIBIT 138 NIHON KOHDEN CORPORATION: REVENUE BY SEGMENT 2021 (%)
  • EXHIBIT 139 NIHON KOHDEN CORPORATION: REVENUE BY SEGMENT 2021 (% SHARE)
  • EXHIBIT 140 SOMNOMED: TOTAL REVENUE 2019-2021 ($ MILLION)
  • EXHIBIT 141 SOMNOMED: REVENUE BY GEOGRAPHY SEGMENT 2021 (%)
  • EXHIBIT 142 RESMED: TOTAL REVENUE 2020-2022 ($ MILLION)
  • EXHIBIT 143 RESMED: R&D EXPENSE 2020-2022 ($ MILLION)
  • EXHIBIT 144 RESMED: TOTAL REVENUE SHARE BY SEGMENT 2022 (%)
  • EXHIBIT 145 RESMED: REVENUE BY GEOGRAPHY 2022 (%)
  • EXHIBIT 146 KONINKLIJKE PHILIPS N.V: TOTAL REVENUE 2019-2021 ($ BILLION)
  • EXHIBIT 147 KONINKLIJKE PHILIPS N.V: R&D EXPENDITURE 2019-2021 ($ MILLION)
  • EXHIBIT 148 KONINKLIJKE PHILIPS N.V: REVENUE BY BUSINESS SEGMENTS 2021 (%)
  • EXHIBIT 149 FISHER & PAYKEL HEALTHCARE: TOTAL REVENUE 2020-2022 ($ MILLION)
  • EXHIBIT 150 FISHER & PAYKEL HEALTHCARE: R&D EXPENDITURE 2020-2022 ($ MILLION)
  • EXHIBIT 151 FISHER & PAYKEL HEALTHCARE: REVENUE SHARE BY SEGMENT 2022 (%)
  • EXHIBIT 152 FISHER & PAYKEL HEALTHCARE: REVENUE SHARE BY GEOGRAPHY 2022 (%)
  • EXHIBIT 153 COMPUMEDICS: TOTAL REVENUE 2020-2022 ($ MILLION)
  • EXHIBIT 154 COMPUMEDICS: REVENUE SHARE BY GEOGRAPHY 2022 (%)
  • EXHIBIT 155 INSPIRE MEDICAL SYSTEMS: TOTAL REVENUE 2019-2021 ($ MILLION)
  • EXHIBIT 156 INSPIRE MEDICAL SYSTEMS: R&D EXPENDITURE 2019-2021 ($ MILLION)
  • EXHIBIT 157 INSPIRE MEDICAL SYSTEMS: REVENUE SHARE BY GEOGRAPHY 2021 (%)

LIST OF TABLES

  • TABLE 1 KEY CAVEATS
  • TABLE 2 CURRENCY CONVERSION 2015-2021
  • TABLE 3 POPULAR AVAILABLE CPAP DEVICES
  • TABLE 4 GLOBAL THERAPEUTIC SLEEP APNEA DEVICES MARKET 2021-2027 ($ MILLION)
  • TABLE 5 GLOBAL THERAPEUTIC SLEEP APNEA DEVICES MARKET 2021-2027 (%)
  • TABLE 6 GLOBAL SLEEP APNEA DEVICES MARKET BY FACIAL INTERFACES 2021-2027 ($ MILLION)
  • TABLE 7 GLOBAL SLEEP APNEA DEVICES MARKET BY FACIAL INTERFACES 2021-2027 (%)
  • TABLE 8 GLOBAL DIAGNOSTICS SLEEP APNEA DEVICES MARKET 2021-2027 ($ MILLION)
  • TABLE 9 GLOBAL DIAGNOSTICS SLEEP APNEA DEVICES MARKET 2021-2027 (%)
  • TABLE 10 GLOBAL SLEEP APNEA DEVICES MARKET BY BETWEEN 41 & 60 YEARS 2021-2027 ($ MILLION)
  • TABLE 11 GLOBAL SLEEP APNEA DEVICES MARKET BY BETWEEN 41 & 60 YEARS 2021-2027 (%)
  • TABLE 12 GLOBAL SLEEP APNEA DEVICES MARKET BY 61 YEARS & ABOVE 2021-2027 ($ MILLION)
  • TABLE 13 GLOBAL SLEEP APNEA DEVICES MARKET BY 61 YEARS & ABOVE 2021-2027 (%)
  • TABLE 14 GLOBAL SLEEP APNEA DEVICES MARKET BY BELOW 40 YEARS 2021-2027 ($ MILLION)
  • TABLE 15 GLOBAL SLEEP APNEA DEVICES MARKET BY BELOW 40 YEARS 2021-2027 (%)
  • TABLE 16 SLEEP DISORDERS AND SYMPTOMS STATISTICS OF THE NORTHWEST ADELAIDE HEALTH STUDY (NWAHS) PARTICIPANTS
  • TABLE 17 GLOBAL SLEEP APNEA DEVICES MARKET BY MALES 2021-2027 ($ MILLION)
  • TABLE 18 GLOBAL SLEEP APNEA DEVICES MARKET BY MALES 2021-2027 (%)
  • TABLE 19 GLOBAL SLEEP APNEA DEVICES MARKET BY FEMALES 2021-2027 ($ MILLION)
  • TABLE 20 GLOBAL SLEEP APNEA DEVICES MARKET BY FEMALES 2021-2027 (%)
  • TABLE 21 GLOBAL SLEEP APNEA DEVICES MARKET BY SLEEP CLINICS/LABS 2021-2027 ($ MILLION)
  • TABLE 22 GLOBAL SLEEP APNEA DEVICES MARKET BY SLEEP CLINICS/LABS 2021-2027 (%)
  • TABLE 23 GLOBAL SLEEP APNEA DEVICES MARKET BY HOME HEALTHCARE SETTINGS 2021-2027 ($ MILLION)
  • TABLE 24 GLOBAL SLEEP APNEA DEVICES MARKET BY HOME HEALTHCARE SETTINGS 2021-2027 (%)
  • TABLE 25 GLOBAL SLEEP APNEA DEVICES MARKET BY HOSPITALS 2021-2027 ($ MILLION)
  • TABLE 26 GLOBAL SLEEP APNEA DEVICES MARKET BY HOSPITALS 2021-2027 (%)
  • TABLE 27 GLOBAL SLEEP APNEA DEVICES MARKET BY OTHER END-USERS 2021-2027 ($ MILLION)
  • TABLE 28 GLOBAL SLEEP APNEA DEVICES MARKET BY OTHER END-USERS 2021-2027 (%)
  • TABLE 29 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY PRODUCT 2021-2027 ($ MILLION)
  • TABLE 30 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY PRODUCT 2021-2027 (%)
  • TABLE 31 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY AGE GROUP 2021-2027 ($ MILLION)
  • TABLE 32 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY AGE GROUP 2021-2027 (%)
  • TABLE 33 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY GENDER 2021-2027 ($ MILLION)
  • TABLE 34 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY GENDER 2021-2027 (%)
  • TABLE 35 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY END USER 2021-2027 ($ MILLION)
  • TABLE 36 SLEEP APNEA DEVICES MARKET IN NORTH AMERICA BY END USER 2021-2027 (%)
  • TABLE 37 SLEEP APNEA DEVICES MARKET IN EUROPE BY PRODUCT 2021-2027 ($ MILLION)
  • TABLE 38 SLEEP APNEA DEVICES MARKET IN EUROPE BY PRODUCT 2021-2027 (%)
  • TABLE 39 SLEEP APNEA DEVICES MARKET IN EUROPE BY AGE GROUP 2021-2027 ($ MILLION)
  • TABLE 40 SLEEP APNEA DEVICES MARKET IN EUROPE BY 2021-2027 (%)
  • TABLE 41 SLEEP APNEA DEVICES MARKET IN EUROPE BY GENDER 2021-2027 ($ MILLION)
  • TABLE 42 SLEEP APNEA DEVICES MARKET IN EUROPE BY GENDER 2021-2027 (%)
  • TABLE 43 SLEEP APNEA DEVICES MARKET IN EUROPE BY END USER 2021-2027 ($ MILLION)
  • TABLE 44 SLEEP APNEA DEVICES MARKET IN EUROPE BY END USER 2021-2027 (%)
  • TABLE 45 SLEEP APNEA DEVICE MARKET IN APAC BY PRODUCT 2021-2027 ($ MILLION)
  • TABLE 46 SLEEP APNEA DEVICE MARKET IN APAC BY PRODUCT 2021-2027 (%)
  • TABLE 47 SLEEP APNEA DEVICE MARKET IN APAC BY AGE GROUP 2021-2027 ($ MILLION)
  • TABLE 48 SLEEP APNEA DEVICE MARKET IN APAC BY AGE GROUP 2021-2027 (%)
  • TABLE 49 SLEEP APNEA DEVICE MARKET IN APAC BY GENDER 2021-2027 ($ MILLION)
  • TABLE 50 SLEEP APNEA DEVICE MARKET IN APAC BY GENDER 2021-2027 (%)
  • TABLE 51 SLEEP APNEA DEVICE MARKET IN APAC BY END USER 2021-2027 ($ MILLION)
  • TABLE 52 SLEEP APNEA DEVICE MARKET IN APAC BY END USER 2021-2027 (%)
  • TABLE 53 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY PRODUCT 2021-2027 ($ MILLION)
  • TABLE 54 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY PRODUCT 2021-2027 (%)
  • TABLE 55 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY AGE GROUP 2021-2027 ($ MILLION)
  • TABLE 56 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY 2021-2027 (%)
  • TABLE 57 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY GENDER 2021-2027 ($ MILLION)
  • TABLE 58 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY GENDER 2021-2027 (%)
  • TABLE 59 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY END USER 2021-2027 ($ MILLION)
  • TABLE 60 SLEEP APNEA DEVICE MARKET IN LATIN AMERICA BY END USER 2021-2027 (%)
  • TABLE 61 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY PRODUCT 2021-2027 ($ MILLION)
  • TABLE 62 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY PRODUCT 2021-2027 (%)
  • TABLE 63 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY AGE GROUP 2021-2027 ($ MILLION)
  • TABLE 64 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY 2021-2027 (%)
  • TABLE 65 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY GENDER 2021-2027 ($ MILLION)
  • TABLE 66 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY GENDER 2021-2027 (%)
  • TABLE 67 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY END USER 2021-2027 ($ MILLION)
  • TABLE 68 SLEEP APNEA DEVICE MARKET IN MIDDLE EAST & AFRICA BY END USER 2021-2027 (%)
  • TABLE 69 LEADING VENDORS BASED ON SLEEP APNEA PRODUCT PORTFOLIO
  • TABLE 70 NIHON KOHDEN CORPORATION: MAJOR PRODUCT OFFERINGS
  • TABLE 71 BMC MEDICAL: MAJOR PRODUCT OFFERINGS
  • TABLE 72 DRIVE DEVILBISS HEALTHCARE: MAJOR PRODUCT OFFERINGS
  • TABLE 73 SOMNOMED: MAJOR PRODUCT OFFERINGS
  • TABLE 74 GLIDEWELL: MAJOR PRODUCT OFFERINGS
  • TABLE 75 RESMED: MAJOR PRODUCT OFFERINGS
  • TABLE 76 KONINKLIJKE PHILIPS N.V: MAJOR PRODUCT OFFERINGS
  • TABLE 77 FISHER & PAYKEL HEALTHCARE: MAJOR PRODUCT OFFERINGS
  • TABLE 78 COMPUMEDICS: MAJOR PRODUCT OFFERINGS
  • TABLE 79 INSPIRE MEDICAL SYSTEMS: MAJOR PRODUCT OFFERINGS
  • TABLE 80 NATUS MEDICAL: MAJOR PRODUCT OFFERINGS
  • TABLE 81 ITAMAR MEDICAL: MAJOR PRODUCT OFFERINGS
  • TABLE 82 APEX MEDICAL: MAJOR PRODUCT OFFERINGS
  • TABLE 83 CADWELL INDUSTRIES: MAJOR PRODUCT OFFERINGS
  • TABLE 84 SOMNOMEDICS: MAJOR PRODUCT OFFERINGS
  • TABLE 85 CLEVELAND MEDICAL DEVICES: MAJOR PRODUCT OFFERINGS
  • TABLE 86 PROSOMNUS SLEEP TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
  • TABLE 87 MEDITAS: MAJOR PRODUCT OFFERINGS
  • TABLE 88 WHITE DENTAL HEALTHCARE: MAJOR PRODUCT OFFERINGS
  • TABLE 89 OVENTUS: MAJOR PRODUCT OFFERINGS
  • TABLE 90 TOMED: MAJOR PRODUCT OFFERINGS
  • TABLE 91 SIGNIFIER MEDICAL TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
  • TABLE 92 APNEAMED: MAJOR PRODUCT OFFERINGS
  • TABLE 93 NYXOAH: MAJOR PRODUCT OFFERINGS
  • TABLE 94 VIVOS THERAPEUTICS: MAJOR PRODUCT OFFERINGS
  • TABLE 95 SOMNOWELL: MAJOR PRODUCT OFFERINGS
  • TABLE 96 REMSLEEP HOLDINGS: MAJOR PRODUCT OFFERINGS
  • TABLE 97 SIESTA MEDICAL: MAJOR PRODUCT OFFERINGS
  • TABLE 98 HORIZON PRIME: MAJOR PRODUCT OFFERINGS
  • TABLE 99 NOX MEDICAL: MAJOR PRODUCT OFFERINGS
  • TABLE 100 ONERA HEALTH: MAJOR PRODUCT OFFERINGS
  • TABLE 101 LIVANOVA: MAJOR PRODUCT OFFERINGS
  • TABLE 102 ZOLL MEDICAL: MAJOR PRODUCT OFFERINGS
  • TABLE 103 BRAEBON MEDICAL: MAJOR PRODUCT OFFERINGS
  • TABLE 104 INVACARE: MAJOR PRODUCT OFFERINGS
  • TABLE 105 BREAS MEDICAL: MAJOR PRODUCT OFFERINGS
  • TABLE 106 GLOBAL SLEEP APNEA DEVICES MARKET BY PRODUCT 2021-2027 ($ MILLION)
  • TABLE 107 GLOBAL SLEEP APNEA DEVICES MARKET BY PRODUCT 2021-2027 (%)
  • TABLE 108 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY PRODUCT 2021-2027 ($ MILLION)
  • TABLE 109 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY PRODUCT 2021-2027 (%)
  • TABLE 110 EUROPE SLEEP APNEA DEVICES MARKET BY PRODUCT 2021-2027 ($ MILLION)
  • TABLE 111 EUROPE SLEEP APNEA DEVICES MARKET BY PRODUCT 2021-2027 (%)
  • TABLE 112 APAC SLEEP APNEA DEVICES MARKET BY PRODUCT 2021-2027 ($ MILLION)
  • TABLE 113 APAC SLEEP APNEA DEVICES MARKET BY PRODUCT 2021-2027 (%)
  • TABLE 114 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY PRODUCT 2021-2027 ($ MILLION)
  • TABLE 115 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY PRODUCT 2021-2027 (%)
  • TABLE 116 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY PRODUCT 2021-2027 ($ MILLION)
  • TABLE 117 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY PRODUCT 2021-2027 (%)
  • TABLE 118 GLOBAL SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021-2027 ($ MILLION)
  • TABLE 119 GLOBAL SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021-2027 (%)
  • TABLE 120 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021-2027 ($ MILLION)
  • TABLE 121 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021-2027 (%)
  • TABLE 122 EUROPE SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021-2027 ($ MILLION)
  • TABLE 123 EUROPE SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021-2027 (%)
  • TABLE 124 APAC SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021-2027 ($ MILLION)
  • TABLE 125 APAC SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021-2027 (%)
  • TABLE 126 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021-2027 ($ MILLION)
  • TABLE 127 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021-2027 (%)
  • TABLE 128 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021-2027 ($ MILLION)
  • TABLE 129 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY AGE GROUP 2021-2027 (%)
  • TABLE 130 GLOBAL SLEEP APNEA DEVICES MARKET BY GENDER 2021-2027 ($ MILLION)
  • TABLE 131 GLOBAL SLEEP APNEA DEVICES MARKET BY GENDER 2021-2027 (%)
  • TABLE 132 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY GENDER 2021-2027 ($ MILLION)
  • TABLE 133 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY GENDER 2021-2027 (%)
  • TABLE 134 EUROPE SLEEP APNEA DEVICES MARKET BY GENDER 2021-2027 ($ MILLION)
  • TABLE 135 EUROPE SLEEP APNEA DEVICES MARKET BY GENDER 2021-2027 (%)
  • TABLE 136 APAC SLEEP APNEA DEVICES MARKET BY GENDER 2021-2027 ($ MILLION)
  • TABLE 137 APAC SLEEP APNEA DEVICES MARKET BY GENDER 2021-2027 (%)
  • TABLE 138 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY GENDER 2021-2027 ($ MILLION)
  • TABLE 139 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY GENDER 2021-2027 (%)
  • TABLE 140 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY GENDER 2021-2027 ($ MILLION)
  • TABLE 141 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY GENDER 2021-2027 (%)
  • TABLE 142 GLOBAL SLEEP APNEA DEVICES MARKET BY END-USER 2021-2027 ($ MILLION)
  • TABLE 143 GLOBAL SLEEP APNEA DEVICES MARKET BY END-USER 2021-2027 (%)
  • TABLE 144 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY END-USER 2021-2027 ($ MILLION)
  • TABLE 145 NORTH AMERICA SLEEP APNEA DEVICES MARKET BY END-USER 2021-2027 (%)
  • TABLE 146 EUROPE SLEEP APNEA DEVICES MARKET BY END-USER 2021-2027 ($ MILLION)
  • TABLE 147 EUROPE SLEEP APNEA DEVICES MARKET BY END-USER 2021-2027 (%)
  • TABLE 148 APAC SLEEP APNEA DEVICES MARKET BY END-USER 2021-2027 ($ MILLION)
  • TABLE 149 APAC SLEEP APNEA DEVICES MARKET BY END-USER 2021-2027 (%)
  • TABLE 150 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY END-USER 2021-2027 ($ MILLION)
  • TABLE 151 LATIN AMERICA SLEEP APNEA DEVICES MARKET BY END-USER 2021-2027 (%)
  • TABLE 152 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY END-USER 2021-2027 ($ MILLION)
  • TABLE 153 MIDDLE EAST & AFRICA SLEEP APNEA DEVICES MARKET BY END-USER 2021-2027 (%)
  • TABLE 154 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 155 GLOBAL SLEEP APNEA DEVICES MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 156 GLOBAL THERAPEUTIC SLEEP APNEA DEVICES MARKET 2021-2027 ($ MILLION)
  • TABLE 157 GLOBAL THERAPEUTIC SLEEP APNEA DEVICES MARKET 2021-2027 (%)
  • TABLE 158 GLOBAL SLEEP APNEA DEVICES MARKET BY FACIAL INTERFACES 2021-2027 ($ MILLION)
  • TABLE 159 GLOBAL SLEEP APNEA DEVICES MARKET BY FACIAL INTERFACES 2021-2027 (%)
  • TABLE 160 GLOBAL DIAGNOSTIC SLEEP APNEA DEVICES MARKET 2021-2027 ($ MILLION)
  • TABLE 161 GLOBAL DIAGNOSTIC SLEEP APNEA DEVICES MARKET 2021-2027 (%)
  • TABLE 162 GLOBAL SLEEP APNEA DEVICES MARKET BY BETWEEN 41 & 60 YEARS 2021-2027 ($ MILLION)
  • TABLE 163 GLOBAL SLEEP APNEA DEVICES MARKET BY BETWEEN 41 & 60 YEARS 2021-2027 (%)
  • TABLE 164 GLOBAL SLEEP APNEA DEVICES MARKET BY 61 YEARS & ABOVE 2021-2027 ($ MILLION)
  • TABLE 165 GLOBAL SLEEP APNEA DEVICES MARKET BY 61 YEARS & ABOVE 2021-2027 (%)
  • TABLE 166 GLOBAL SLEEP APNEA DEVICES MARKET BY BELOW 40 YEARS 2021-2027 ($ MILLION)
  • TABLE 167 GLOBAL SLEEP APNEA DEVICES MARKET BY BELOW 40 YEARS 2021-2027 (%)
  • TABLE 168 GLOBAL SLEEP APNEA DEVICES MARKET BY MALES 2021-2027 ($ MILLION)
  • TABLE 169 GLOBAL SLEEP APNEA DEVICES MARKET BY MALES 2021-2027 (%)
  • TABLE 170 GLOBAL SLEEP APNEA DEVICES MARKET BY FEMALES 2021-2027 ($ MILLION)
  • TABLE 171 GLOBAL SLEEP APNEA DEVICES MARKET BY FEMALES 2021-2027 (%)
  • TABLE 172 GLOBAL SLEEP APNEA DEVICES MARKET BY SLEEP CLINICS/LABS 2021-2027 ($ MILLION)
  • TABLE 173 GLOBAL SLEEP APNEA DEVICES MARKET BY SLEEP CLINICS/LABS 2021-2027 (%)
  • TABLE 174 GLOBAL SLEEP APNEA DEVICES MARKET BY HOME HEALTHCARE SETTINGS 2021-2027 ($ MILLION)
  • TABLE 175 GLOBAL SLEEP APNEA DEVICES MARKET BY HOME HEALTHCARE SETTINGS 2021-2027 (%)
  • TABLE 176 GLOBAL SLEEP APNEA DEVICES MARKET BY HOSPITALS 2021-2027 ($ MILLION)
  • TABLE 177 GLOBAL SLEEP APNEA DEVICES MARKET BY HOSPITALS 2021-2027 (%)
  • TABLE 178 GLOBAL SLEEP APNEA DEVICES MARKET BY OTHER END-USERS 2021-2027 ($ MILLION)
  • TABLE 179 GLOBAL SLEEP APNEA DEVICES MARKET BY OTHER END-USERS 2021-2027 (%)
目次
Product Code: ARZ221110

The global sleep apnea devices market is expected to grow at a CAGR of 7.07% during 2022-2027.

MARKET OUTLOOK

The growing sleep apnea devices market is attributed to factors such as the high prevalence of sleep apnea, increasing potential risk factors, technological advancements in sleep apnea devices, and an increasingly aging population. Obstructive sleep apnea (OSA) is particularly prevalent in adults with mild to moderate severity (14% in men and 5% in women) and is becoming more common, partly due to the increasing prevalence of obesity worldwide. The global prevalence of OSA is estimated at 1 billion people, and in some countries, the prevalence in the general population is estimated to exceed 50%.

In developed regions such as North America and Europe, sleep apnea devices are already widely held for OSA. The sleep apnea devices market in these regions is witnessing the entry of many new players and start-ups, promising to provide different products that meet customer demand and market trends. The current trend is smart sleep apnea devices, which are being explored by existing and new players in the market.

The increasing prevalence of obesity and other lifestyle diseases in both developed and developing countries and the rising rate of diagnosis of sleep apnea is presenting a larger patient demographic which requires treatment or management of sleep apnea. This, combined with the increasing number of sleep physicians, technicians, and sleep clinics globally, is facilitating the global sleep apnea devices market's growth.

MARKET TRENDS & OPPORTUNITIES

The Emergence of Artificial Intelligence in Sleep Apnea Treatment

  • The convergence of large data sets, increased computing power, and algorithm advances have opened the door to Artificial intelligence (AI) applications across various industries.
  • AHI is only a consideration, and the ability to predict side effects and response to treatment is limited. AI offers the opportunity to consider more factors than AHI. AHI provides more information about the severity and OSA endophenotype and can influence treatment choices.
  • Artificial intelligence (AI) will pave the way for screening and diagnosing OSA, reduce costly PSG deployment, and streamline the path to effective treatment in the sleep apnea devices market.

Growing Demand and Advancements in Home Sleep Apnea Tests (HSATs)

  • In December 2007, the American Academy of Sleep Medicine (AASM) task force published guidelines for the use of unattended wearable monitors (PM) for the diagnosis of obstructive sleep apnea (OSA) in adults. In March 2017, considering recent technological advances in the sleep apnea devices market, the AASM revised its guidelines to include home sleep testing (HST) measuring peripheral arterial tonometry (PAT), oximetry, and actigraphy in obstructive sleep.
  • Itamar Medical, a leading player in the sleep apnea diagnostics market, offers WatchPat, the market-leading sleep apnea diagnostic device that uses this proprietary PAT technology.
  • ResMed launches a three-part "Onesleeptest" service for NightOwl after acquiring the device's manufacturer Ectosense. The onesleeptest device accurately tracks and delivers results from a certified sleep specialist within 3-5 business days, making it the ideal solution for testing sleep quality from the comfort and safety of their own home during the pandemic.

Technological Advancements in Continuous Positive Airway Pressure (CPAP) Therapy

  • CPAP has changed significantly since its inception in 1981. Devices developed decades ago were heavier, noisier, and had limited performance compared to today's slim, lightweight devices.
  • An outstanding innovation is the Automatic Airway Pressure Device (AutoPAP); with AutoPAP, airway pressure begins with light to meet lower pressure needs. When a patient falls asleep, the device automatically adjusts to increase positive airway pressure and keep the respiratory system open. Some CPAP machines in the sleep apnea devices market have the intellectual ability to record the mask on time when the patient breathes into the mask, when the air supply is started and when the mask is removed, and the air stops.
  • Another notable feature of CPAP today is its low noise level. In addition to size and weight, the CPAP machine's ability to deliver 20 cm H2O-filtered air to patients with a slight humping is just as refreshing for doctors, patients, and bed partners. The days of sleeping next to mechanically generated hurricanes are over; thanks to a lightweight blower, it is well insulated with CPAP machines.

SEGMENTATION INSIGHTS

PRODUCTS INSIGHTS

The therapeutic devices segment accounts for the highest share of 73.98% in the global sleep apnea devices market by products segment. The therapeutics device segment comprises positive airway pressure (PAP) devices, oral appliances, adaptive servo-ventilators, implants, airway clearance systems, oxygen therapy devices, & accessories. The prevalence of OSA is increasing significantly in developed and developing countries. The prevalence of OSA is rising due to the exponentially growing potential risk factors such as obesity, the aging population, smoking, a sedentary lifestyle, etc. Positive airway pressure (PAP) therapy is a common term used for all sleep apnea treatments that use compressed air flow to support the airways during sleep. The PAP machines continuously witness technological advancements; for instance, these devices combine the variable positive air pressure (VPAP), a relatively new technology, with the automatic adjustments of classic BiPAP therapy's dual-level pressure settings.

The global sleep apnea devices market by facial interfaces was valued at USD 916.7 million in 2021. Continuous positive airway pressure (CPAP) masks and headgear are available in various styles and sizes to help treat sleep apnea. Because everyone's needs, preferences, and face shapes are different, patients may need to try different mask styles before finding the one that works best for them. A mask is used to direct air through the therapy device. Most masks have built-in vents to expel exhaled air.

Segmentation by Product:

  • Therapeutic Devices
  • Facial Interfaces
  • Diagnostics Devices

AGE GROUP INSIGHTS

The global sleep apnea devices market by age group is segmented into between 41 & 60 years, 61 years & above, and below 40 years. Between 41 & 60 years accounted for a larger share, 51.06% in the global market. The 41-60 years of the age group of people are the working adult population facing daily issues from the workplace to the home. The major risk factors for developing OSA and its related symptoms, like snoring in this age group, are work-related stress, alcohol consumption, chronic smoking, and obesity.

Segmentation by Age Group:

  • Between 41 & 60 Years
  • 61 Years & Above
  • Below 40 Years

GENDER INSIGHTS

The male segment accounted for the highest share of 60.50% in the global sleep apnea devices market by gender segment. OSA is the usual sleep-related breathing disorder, and it is most common in older males. In North America, the estimated prevalence is about 15-30% in males. Most patients with OSA complain of daytime sleepiness or report loud snoring, wheezing, choking, sniffling, or cessation of breathing while their bed partner sleeps. These symptoms are often identified during assessment for another condition, wellness maintenance, or preoperative screening. Women report greater reporting of OSA symptoms for their bed partners. Obesity is a significant risk factor for sleep apnea, and most OSA patients are overweight. Men are more likely than women to increase AHI for a given weight gain, regardless of baseline weight, waist size, age, or race. The global male sleep apnea devices market is expected to grow at a CAGR of 7.30% during the forecast period.

Segmentation by Gender:

  • Males
  • Females

END-USER INSIGHTS

Among all end-users, the sleep clinics/labs segment accounted for the highest share of 39.14% in the global sleep apnea devices market. With the increasing prevalence of sleep disorders, the requirement for sleep labs is also rising. Accurate diagnosis is essential for the determination of sleeping disorders. Because of higher medical accuracy, polysomnography (PSG) is the most preferred technology for diagnosis.

With the increasing incidences of sleeping disorders, the demand for sleep facilities and clinics equipped with technologically advanced PSGs is increasing. Nearly 3,500 sleep labs or clinics have been established across the US since they began in the 1970s. The American Academy of Sleep Medicine has accredited about 1,400 of these facilities. The need for these facilities is supported by research; recent findings relate sleep disturbances to an increased risk of heart attack, stroke, diabetes, rheumatoid arthritis, metabolic disorders, and other illnesses.

Segmentation by End-User:

  • Sleep Clinics/Labs
  • Home Healthcare Settings
  • Hospitals
  • Others

GEOGRAPHICAL INSIGHTS

The global sleep apnea devices market is categorized into regions of North America, Europe, APAC, Latin America, and the Middle East & Africa. In 2021, North America dominated the global market and accounted for a revenue share of 40.43%. The region's market growth depends on various factors, including a high prevalence of sleep disorders, a decrease in sleep patterns, lifestyle changes, and the presence of various vendors, including key players, start-ups, and sleep-based companies. The region has witnessed a high prevalence of OSA; for instance, the prevalence of OSA in North America is nearly 15 to 30% in men and 10 to 15% in women. The presence of sleep apnea device manufacturers boosts the region's market share, making it more significant than any other region globally.

Europe's sleep apnea devices market was valued at USD 1.9 billion in 2021. In Europe, the market is driven by the growing use of technology to manage sleep disorders. Technology, such as PAP devices, innovative OAT devices, and diagnostics devices, is getting traction in the European market. APAC proves to be the region with the fastest growth rate among other regions. It is expected to continue its growth during the forecast period and affect the global sleep apnea devices market with its power to manufacture large-scale products. China, Japan, and India are the leading countries in the APAC sleep apnea device, where China is dominating the sleep apnea devices market with its innovative solutions.

Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK
  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Turkey

VENDOR LANDSCAPE

The global sleep apnea devices market is highly diversified, with several global and local players offering a diverse range of sleep apnea devices such as PAP devices, oral devices, implants, and other devices. The global players focus on developing innovative products and expanding their product portfolio to remain competitive. They are investing extensively in R&D and product development activities to expand their product portfolio. Manufacturers in the global sleep apnea devices market, such as ResMed, Koninklijke Philips N.V, BMC Medical Natus Medical, Itamar Medical, inspire medical system, Compumedics, and Drive DeVilbiss Healthcare, are continuously focusing on product development and offering sophisticated sleep apnea device with new technology to increase their industry presence.

Key Company Profiles

  • Nihon Kohden Corporation
  • BMC Medical
  • Drive DeVilbiss Healthcare
  • SomnoMed
  • Glidewell
  • ResMed
  • Koninklijke Philips N.V
  • Fisher & Paykel Healthcare
  • Compumedics Limited
  • Inspire Medical Systems
  • Natus Medical
  • Itamar Medical

Other Prominent Vendors

  • Apex Medical
  • Cadwell Industries
  • SOMNOmedics
  • Cleveland Medical Devices
  • ProSomnus Sleep Technologies
  • MEDITAS
  • White Dental Healthcare
  • Oventus
  • Tomed
  • Signifier Medical Technologies
  • ApneaMed
  • Nyxoah
  • Vivos Therapeutics
  • Somnowell
  • RemSleep Holdings
  • Siesta Medical
  • Horizon Prime
  • Nox Medical
  • Onera Health
  • LivaNova
  • ZOLL Medical
  • BRAEBON Medical
  • Invacare
  • Breas Medical

Recent Advancements In The Global Sleep Apnea Devices Market

  • In April 2022, Fisher & Paykel Healthcare announced the launch of the F&P Evora Full in the US, a compact full-face mask for OSA.
  • In June 2021, Oventus Medical signed a partnership agreement with Aeroflow Healthcare to bring Oventus' OSA treatment solutions, including O2Vent Optima, directly to consumers through US sleep clinics.
  • In August 2021, ResMed launched a new PAP device in the US sleep apnea devices market to help hundreds of millions of people with sleep apnea.
  • In February 2021, Oventus Medical launched 02Vent Optima, a customizable oral appliance therapy device that offers an alternative to CPAP therapy through GoPAPfree in the US.
  • In December 2021, ZOLL Medical Corporation, a subsidiary of Asahi Kasei that manufactures medical devices and related software solutions, announced the acquisition of Itamar Medical Ltd., a medical device and digital health company that provides home testing services.

KEY QUESTIONS ANSWERED

  • 1. How big is the sleep apnea market?
  • 2. What is the growth rate of the global sleep apnea devices market?
  • 3. What are the rising trends in the sleep apnea devices market?
  • 4. Which are the key companies in the global sleep apnea devices market?
  • 5. Which are the popular CPAP devices available in the market?
  • 6. Which holds the most significant global sleep apnea devices market share?

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

  • 4.1 MARKET DEFINITION
    • 4.1.1 INCLUSIONS
    • 4.1.2 EXCLUSIONS
    • 4.1.3 MARKET ESTIMATION CAVEATS
  • 4.2 BASE YEAR
  • 4.3 SCOPE OF THE STUDY
    • 4.3.1 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

  • 5.1 KEY CAVEATS
  • 5.2 CURRENCY CONVERSION
  • 5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 PREMIUM INSIGHTS

  • 7.1 MARKET OVERVIEW
    • 7.1.1 MARKET DYNAMICS
    • 7.1.2 MARKET SEGMENTATION
    • 7.1.3 VENDOR ANALYSIS
    • 7.1.4 RECENT ADVANCES

8 INTRODUCTION

  • 8.1 OVERVIEW
    • 8.1.1 RISK FACTORS
    • 8.1.2 DIAGNOSIS OF SLEEP APNEA
    • 8.1.3 TREATMENT FOR SLEEP APNEA

9 MARKET OPPORTUNITIES & TRENDS

  • 9.1 IMPLEMENTATION OF AI IN SLEEP APNEA TREATMENTS
  • 9.2 GROWING DEMAND AND ADVANCES IN HOME SLEEP APNEA TESTS (HSATS)
  • 9.3 GROWING ADOPTION OF TELEMEDICINE, MHEALTH IN SLEEP APNEA TREATMENT
  • 9.4 GROWING POPULARITY OF NON-CPAP DEVICES FOR SLEEP APNEA TREATMENT

10 MARKET GROWTH ENABLERS

  • 10.1 IMPROVEMENTS IN SLEEP APNEA DIAGNOSIS
  • 10.2 TECHNOLOGICAL ADVANCES IN CPAP THERAPY
  • 10.3 INCREASING TARGET PATIENT POPULATION
  • 10.4 HIGH GROWTH POTENTIAL FOR UPPER AIRWAY STIMULATION THERAPY (IMPLANT) SYSTEM

11 MARKET RESTRAINTS

  • 11.1 PRESENCE OF NUMEROUS UNDIAGNOSED PATIENTS
  • 11.2 HIGH COST OF SLEEP APNEA DEVICES
  • 11.3 AVAILABILITY OF SURGICAL OPTION TO TREAT SLEEP APNEA
  • 11.4 LACK OF PATIENT ADHERENCE TO CPAP DEVICE

12 MARKET LANDSCAPE

  • 12.1 MARKET OVERVIEW
  • 12.2 MARKET SIZE & FORECAST
    • 12.2.1 INSIGHTS BY GEOGRAPHY SEGMENTATION
    • 12.2.2 INSIGHTS BY PRODUCT SEGMENTATION
    • 12.2.3 INSIGHTS BY AGE GROUP SEGMENTATION
    • 12.2.4 INSIGHTS BY GENDER SEGMENTATION
    • 12.2.5 INSIGHTS BY END-USER SEGMENTATION
  • 12.3 FIVE FORCES ANALYSIS
    • 12.3.1 THREAT OF NEW ENTRANTS
    • 12.3.2 BARGAINING POWER OF SUPPLIERS
    • 12.3.3 BARGAINING POWER OF BUYERS
    • 12.3.4 THREAT OF SUBSTITUTES
    • 12.3.5 COMPETITIVE RIVALRY

13 PRODUCT

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
  • 13.3 THERAPEUTIC DEVICES
    • 13.3.1 MARKET OVERVIEW
    • 13.3.2 MARKET SIZE & FORECAST
    • 13.3.3 MARKET BY GEOGRAPHY
  • 13.4 FACIAL INTERFACES
    • 13.4.1 MARKET OVERVIEW
    • 13.4.2 MARKET SIZE & FORECAST
    • 13.4.3 MARKET BY GEOGRAPHY
  • 13.5 DIAGNOSTICS DEVICES
    • 13.5.1 MARKET OVERVIEW
    • 13.5.2 MARKET SIZE & FORECAST
    • 13.5.3 MARKET BY GEOGRAPHY

14 AGE GROUP

  • 14.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 14.2 MARKET OVERVIEW
  • 14.3 BETWEEN 41 & 60 YEARS
    • 14.3.1 MARKET OVERVIEW
    • 14.3.2 MARKET SIZE & FORECAST
    • 14.3.3 MARKET BY GEOGRAPHY
  • 14.4 61 YEARS & ABOVE
    • 14.4.1 MARKET OVERVIEW
    • 14.4.2 MARKET SIZE & FORECAST
    • 14.4.3 MARKET BY GEOGRAPHY
  • 14.5 BELOW 40 YEARS
    • 14.5.1 MARKET OVERVIEW
    • 14.5.2 MARKET SIZE & FORECAST
    • 14.5.3 MARKET BY GEOGRAPHY

15 GENDER

  • 15.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 15.2 MARKET OVERVIEW
  • 15.3 MALES
    • 15.3.1 MARKET OVERVIEW
    • 15.3.2 MARKET SIZE & FORECAST
    • 15.3.3 MARKET BY GEOGRAPHY
  • 15.4 FEMALES
    • 15.4.1 MARKET OVERVIEW
    • 15.4.2 MARKET SIZE & FORECAST
    • 15.4.3 MARKET BY GEOGRAPHY

16 END-USER

  • 16.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 16.2 MARKET OVERVIEW
  • 16.3 SLEEP CLINICS/LABS
    • 16.3.1 MARKET OVERVIEW
    • 16.3.2 MARKET SIZE & FORECAST
    • 16.3.3 MARKET BY GEOGRAPHY
  • 16.4 HOME HEALTHCARE SETTINGS
    • 16.4.1 MARKET OVERVIEW
    • 16.4.2 MARKET SIZE & FORECAST
    • 16.4.3 MARKET BY GEOGRAPHY
  • 16.5 HOSPITALS
    • 16.5.1 MARKET OVERVIEW
    • 16.5.2 MARKET SIZE & FORECAST
    • 16.5.3 MARKET BY GEOGRAPHY
  • 16.6 OTHERS
    • 16.6.1 MARKET OVERVIEW
    • 16.6.2 MARKET SIZE & FORECAST
    • 16.6.3 MARKET BY GEOGRAPHY

17 GEOGRAPHY

  • 17.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 17.2 GEOGRAPHIC OVERVIEW

18 NORTH AMERICA

  • 18.1 MARKET OVERVIEW
  • 18.2 MARKET SIZE & FORECAST
    • 18.2.1 NORTH AMERICA: PRODUCT SEGMENTATION
    • 18.2.2 NORTH AMERICA: AGE GROUP SEGMENTATION
    • 18.2.3 NORTH AMERICA: GENDER SEGMENTATION
    • 18.2.4 NORTH AMERICA: END USER SEGMENTATION
  • 18.3 KEY COUNTRIES
    • 18.3.1 US: MARKET SIZE & FORECAST
    • 18.3.2 CANADA: MARKET SIZE & FORECAST

19 EUROPE

  • 19.1 MARKET OVERVIEW
  • 19.2 MARKET SIZE & FORECAST
    • 19.2.1 EUROPE: PRODUCT SEGMENTATION
    • 19.2.2 EUROPE: AGE GROUP SEGMENTATION
    • 19.2.3 EUROPE: GENDER SEGMENTATION
    • 19.2.4 EUROPE: END USER SEGMENTATION
  • 19.3 KEY COUNTRIES
    • 19.3.1 GERMANY: MARKET SIZE & FORECAST
    • 19.3.2 FRANCE: MARKET SIZE & FORECAST
    • 19.3.3 UK: MARKET SIZE & FORECAST
    • 19.3.4 ITALY: MARKET SIZE & FORECAST
    • 19.3.5 SPAIN: MARKET SIZE & FORECAST

20 APAC

  • 20.1 MARKET OVERVIEW
  • 20.2 MARKET SIZE & FORECAST
    • 20.2.1 APAC: PRODUCT SEGMENTATION
    • 20.2.2 APAC: AGE GROUP SEGMENTATION
    • 20.2.3 APAC: GENDER SEGMENTATION
    • 20.2.4 APAC: END USER SEGMENTATION
  • 20.3 KEY COUNTRIES
    • 20.3.1 CHINA: MARKET SIZE & FORECAST
    • 20.3.2 JAPAN: MARKET SIZE & FORECAST
    • 20.3.3 INDIA: MARKET SIZE & FORECAST
    • 20.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
    • 20.3.5 AUSTRALIA: MARKET SIZE & FORECAST

21 LATIN AMERICA

  • 21.1 MARKET OVERVIEW
  • 21.2 MARKET SIZE & FORECAST
    • 21.2.1 LATIN AMERICA: PRODUCT SEGMENTATION
    • 21.2.2 LATIN AMERICA: AGE GROUP SEGMENTATION
    • 21.2.3 LATIN AMERICA: GENDER SEGMENTATION
    • 21.2.4 LATIN AMERICA: END USER SEGMENTATION
  • 21.3 KEY COUNTRIES
    • 21.3.1 BRAZIL: MARKET SIZE & FORECAST
    • 21.3.2 MEXICO: MARKET SIZE & FORECAST
    • 21.3.3 ARGENTINA: MARKET SIZE & FORECAST

22 MIDDLE EAST & AFRICA

  • 22.1 MARKET OVERVIEW
  • 22.2 MARKET SIZE & FORECAST
    • 22.2.1 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION
    • 22.2.2 MIDDLE EAST & AFRICA: AGE GROUP SEGMENTATION
    • 22.2.3 MIDDLE EAST & AFRICA: GENDER SEGMENTATION
    • 22.2.4 MIDDLE EAST & AFRICA: END USER SEGMENTATION
  • 22.3 KEY COUNTRIES
    • 22.3.1 TURKEY: MARKET SIZE & FORECAST
    • 22.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
    • 22.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST

23 COMPETITIVE LANDSCAPE

  • 23.1 COMPETITION OVERVIEW
  • 23.2 MARKET SHARE ANALYSIS

24 KEY COMPANY PROFILES

  • 24.1 NIHON KOHDEN CORPORATION
    • 24.1.1 BUSINESS OVERVIEW
    • 24.1.2 NIHON KOHDEN CORPORATION IN SLEEP APNEA MARKET
    • 24.1.3 PRODUCT OFFERINGS
    • 24.1.4 KEY STRATEGIES
    • 24.1.5 KEY STRENGTHS
    • 24.1.6 KEY OPPORTUNITIES
  • 24.2 BMC MEDICAL
    • 24.2.1 BUSINESS OVERVIEW
    • 24.2.2 BMC MEDICAL IN SLEEP APNEA MARKET
    • 24.2.3 PRODUCT OFFERINGS
    • 24.2.4 KEY STRATEGIES
    • 24.2.5 KEY STRENGTHS
    • 24.2.6 KEY OPPORTUNITIES
  • 24.3 DRIVE DEVILBISS HEALTHCARE
    • 24.3.1 BUSINESS OVERVIEW
    • 24.3.2 DRIVE DEVILBISS HEALTHCARE IN SLEEP APNEA MARKET
    • 24.3.3 PRODUCT OFFERINGS
    • 24.3.4 KEY STRATEGIES
    • 24.3.5 KEY STRENGTHS
    • 24.3.6 KEY OPPORTUNITIES
  • 24.4 SOMNOMED
    • 24.4.1 BUSINESS OVERVIEW
    • 24.4.2 SOMNOMED IN SLEEP APNEA MARKET
    • 24.4.3 PRODUCT OFFERINGS
    • 24.4.4 KEY STRATEGIES
    • 24.4.5 KEY STRENGTHS
    • 24.4.6 KEY OPPORTUNITIES
  • 24.5 GLIDEWELL
    • 24.5.1 BUSINESS OVERVIEW
    • 24.5.2 GLIDEWELL IN SLEEP APNEA MARKET
    • 24.5.3 PRODUCT OFFERINGS
    • 24.5.4 KEY STRATEGIES
    • 24.5.5 KEY STRENGTHS
    • 24.5.6 KEY OPPORTUNITIES
  • 24.6 RESMED
    • 24.6.1 BUSINESS OVERVIEW
    • 24.6.2 RESMED IN SLEEP APNEA MARKET
    • 24.6.3 PRODUCT OFFERINGS
    • 24.6.4 KEY STRATEGIES
    • 24.6.5 KEY STRENGTHS
    • 24.6.6 KEY OPPORTUNITIES
  • 24.7 KONINKLIJKE PHILIPS N.V
    • 24.7.1 BUSINESS OVERVIEW
    • 24.7.2 KONINKLIJKE PHILIPS N.V IN SLEEP APNEA MARKET
    • 24.7.3 PRODUCT OFFERINGS
    • 24.7.4 KEY STRATEGIES
    • 24.7.5 KEY STRENGTHS
    • 24.7.6 KEY OPPORTUNITIES
  • 24.8 FISHER & PAYKEL HEALTHCARE
    • 24.8.1 BUSINESS OVERVIEW
    • 24.8.2 FISHER & PAYKEL HEALTHCARE IN SLEEP APNEA MARKET
    • 24.8.3 PRODUCT OFFERINGS
    • 24.8.4 KEY STRATEGIES
    • 24.8.5 KEY STRENGTHS
    • 24.8.6 KEY OPPORTUNITIES
  • 24.9 COMPUMEDICS LIMITED
    • 24.9.1 BUSINESS OVERVIEW
    • 24.9.2 COMPUMEDICS IN SLEEP APNEA MARKET
    • 24.9.3 PRODUCT OFFERINGS
    • 24.9.4 KEY STRATEGIES
    • 24.9.5 KEY STRENGTHS
    • 24.9.6 KEY OPPORTUNITIES
  • 24.10 INSPIRE MEDICAL SYSTEMS
    • 24.10.1 BUSINESS OVERVIEW
    • 24.10.2 INSPIRE MEDICAL SYSTEMS IN SLEEP APNEA MARKET
    • 24.10.3 PRODUCT OFFERINGS
    • 24.10.4 KEY STRATEGIES
    • 24.10.5 KEY STRENGTHS
    • 24.10.6 KEY OPPORTUNITIES
  • 24.11 NATUS MEDICAL
    • 24.11.1 BUSINESS OVERVIEW
    • 24.11.2 NATUS MEDICAL IN SLEEP APNEA MARKET
    • 24.11.3 PRODUCT OFFERINGS
    • 24.11.4 KEY STRATEGIES
    • 24.11.5 KEY STRENGTHS
    • 24.11.6 KEY OPPORTUNITIES
  • 24.12 ITAMAR MEDICAL
    • 24.12.1 BUSINESS OVERVIEW
    • 24.12.2 ITAMAR MEDICAL IN SLEEP APNEA DEVICES MARKET
    • 24.12.3 PRODUCT OFFERINGS
    • 24.12.4 KEY STRATEGIES
    • 24.12.5 KEY STRENGTHS
    • 24.12.6 KEY OPPORTUNITIES

25 OTHER PROMINENT VENDORS

  • 25.1 APEX MEDICAL
    • 25.1.1 BUSINESS OVERVIEW
    • 25.1.2 PRODUCT OFFERINGS
  • 25.2 CADWELL INDUSTRIES
    • 25.2.1 BUSINESS OVERVIEW
    • 25.2.2 PRODUCT OFFERINGS
  • 25.3 SOMNOMEDICS
    • 25.3.1 BUSINESS OVERVIEW
    • 25.3.2 PRODUCT OFFERINGS
  • 25.4 CLEVELAND MEDICAL DEVICES
    • 25.4.1 BUSINESS OVERVIEW
    • 25.4.2 PRODUCT OFFERINGS
  • 25.5 PROSOMNUS SLEEP TECHNOLOGIES
    • 25.5.1 BUSINESS OVERVIEW
    • 25.5.2 PRODUCT OFFERINGS
  • 25.6 MEDITAS
    • 25.6.1 BUSINESS OVERVIEW
    • 25.6.2 PRODUCT OFFERINGS
  • 25.7 WHITE DENTAL HEALTHCARE
    • 25.7.1 BUSINESS OVERVIEW
    • 25.7.2 PRODUCT OFFERINGS
  • 25.8 OVENTUS
    • 25.8.1 BUSINESS OVERVIEW
    • 25.8.2 PRODUCT OFFERINGS
  • 25.9 TOMED
    • 25.9.1 BUSINESS OVERVIEW
    • 25.9.2 PRODUCT OFFERINGS
  • 25.10 SIGNIFIER MEDICAL TECHNOLOGIES
    • 25.10.1 BUSINESS OVERVIEW
    • 25.10.2 PRODUCT OFFERINGS
  • 25.11 APNEAMED
    • 25.11.1 BUSINESS OVERVIEW
    • 25.11.2 PRODUCT OFFERINGS
  • 25.12 NYXOAH
    • 25.12.1 BUSINESS OVERVIEW
    • 25.12.2 PRODUCT OFFERINGS
  • 25.13 VIVOS THERAPEUTICS
    • 25.13.1 BUSINESS OVERVIEW
    • 25.13.2 PRODUCT OFFERINGS
  • 25.14 SOMNOWELL
    • 25.14.1 BUSINESS OVERVIEW
    • 25.14.2 PRODUCT OFFERINGS
  • 25.15 REMSLEEP HOLDINGS
    • 25.15.1 BUSINESS OVERVIEW
    • 25.15.2 PRODUCT OFFERINGS
  • 25.16 SIESTA MEDICAL
    • 25.16.1 BUSINESS OVERVIEW
    • 25.16.2 PRODUCT OFFERINGS
  • 25.17 HORIZON PRIME
    • 25.17.1 BUSINESS OVERVIEW
    • 25.17.2 PRODUCT OFFERINGS
  • 25.18 NOX MEDICAL
    • 25.18.1 BUSINESS OVERVIEW
    • 25.18.2 PRODUCT OFFERINGS
  • 25.19 ONERA HEALTH
    • 25.19.1 BUSINESS OVERVIEW
    • 25.19.2 PRODUCT OFFERINGS
  • 25.20 LIVANOVA
    • 25.20.1 BUSINESS OVERVIEW
    • 25.20.2 PRODUCT OFFERINGS
  • 25.21 ZOLL MEDICAL
    • 25.21.1 BUSINESS OVERVIEW
    • 25.21.2 PRODUCT OFFERINGS
  • 25.22 BRAEBON MEDICAL
    • 25.22.1 BUSINESS OVERVIEW
    • 25.22.2 PRODUCT OFFERINGS
  • 25.23 INVACARE
    • 25.23.1 BUSINESS OVERVIEW
    • 25.23.2 PRODUCT OFFERINGS
  • 25.24 BREAS MEDICAL
    • 25.24.1 BUSINESS OVERVIEW
    • 25.24.2 PRODUCT OFFERINGS

26 REPORT SUMMARY

  • 26.1 KEY TAKEAWAYS
  • 26.2 STRATEGIC RECOMMENDATIONS.

27 QUANTITATIVE SUMMARY

  • 27.1 MARKET BY PRODUCT
    • 27.1.1 NORTH AMERICA: PRODUCT SEGMENTATION
    • 27.1.2 EUROPE: PRODUCT SEGMENTATION
    • 27.1.3 APAC: PRODUCT SEGMENTATION
    • 27.1.4 LATIN AMERICA: PRODUCT SEGMENTATION
    • 27.1.5 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION
  • 27.2 MARKET BY AGE GROUP
    • 27.2.1 NORTH AMERICA: AGE GROUP SEGMENTATION
    • 27.2.2 EUROPE: AGE GROUP SEGMENTATION
    • 27.2.3 APAC: AGE GROUP SEGMENTATION
    • 27.2.4 LATIN AMERICA: AGE GROUP SEGMENTATION
    • 27.2.5 MIDDLE EAST & AFRICA: AGE GROUP SEGMENTATION
  • 27.3 MARKET BY GENDER
    • 27.3.1 NORTH AMERICA: GENDER SEGMENTATION
    • 27.3.2 EUROPE: GENDER SEGMENTATION
    • 27.3.3 APAC: GENDER SEGMENTATION
    • 27.3.4 LATIN AMERICA: GENDER SEGMENTATION
    • 27.3.5 MIDDLE EAST & AFRICA: GENDER SEGMENTATION
  • 27.4 MARKET BY END USER
    • 27.4.1 NORTH AMERICA: END USER SEGMENTATION
    • 27.4.2 EUROPE: END USER SEGMENTATION
    • 27.4.3 APAC: END USER SEGMENTATION
    • 27.4.4 LATIN AMERICA: END USER SEGMENTATION
    • 27.4.5 MIDDLE EAST & AFRICA: END USER SEGMENTATION
  • 27.5 MARKET BY GEOGRAPHY
    • 27.5.1 THERAPEUTIC DEVICES: GEOGRAPHY SEGMENTATION
    • 27.5.2 FACIAL INTERFACES: GEOGRAPHY SEGMENTATION
    • 27.5.3 DIAGNOSTICS DEVICE: GEOGRAPHY SEGMENTATION
    • 27.5.4 BETWEEN 41 & 60 YEARS: GEOGRAPHY SEGMENTATION
    • 27.5.5 61 YEARS & ABOVE: GEOGRAPHY SEGMENTATION
    • 27.5.6 BELOW 40 YEARS: GEOGRAPHY SEGMENTATION
    • 27.5.7 MALES: GEOGRAPHY SEGMENTATION
    • 27.5.8 FEMALES: GEOGRAPHY SEGMENTATION
    • 27.5.9 SLEEP CLINICS/LABS: GEOGRAPHY SEGMENTATION
    • 27.5.10 HOME HEALTHCARE SETTINGS: GEOGRAPHY SEGMENTATION
    • 27.5.11 HOSPITALS: GEOGRAPHY SEGMENTATION
    • 27.5.12 OTHERS: GEOGRAPHY SEGMENTATION

28 APPENDIX

  • 28.1 ABBREVIATIONS